Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Ajai Chari; Attaya Suvannasankha; Joseph W Fay; Bertrand Arnulf; Jonathan L Kaufman; Jainulabdeen J Ifthikharuddin; Brendan M Weiss; Amrita Krishnan; Suzanne Lentzsch; Raymond Comenzo

doi:10.1182/blood-2017-05-785246

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Identifier:nobleid.org/w1/20260522/2D9B40CE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D9B40CE.svg?ark=w1%2F20260522%2F2D9B40CE)](https://nobleid.org/work/w1/20260522/2D9B40CE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Jainulabdeen J Ifthikharuddin

Claim authorship of this work

Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma.

Identifier:nobleid.org/w1/20260522/2D9B40CE

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/2D9B40CE.svg?ark=w1%2F20260522%2F2D9B40CE)](https://nobleid.org/work/w1/20260522/2D9B40CE)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Jainulabdeen J Ifthikharuddin

Claim authorship of this work